Overall, these findings suggest a correlation between the quantification of CD33+CD11b+HLA-DR-CD14+ cells and CD33+CD11b+HLA-DR-CD66b+ cells and the severity of COVID-19. The gene discussed is ITGAM; the disease is COVID-19.